These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3656121)

  • 21. Reduced muscarinic receptor binding in tissues of rats tolerant to the insecticide disulfoton.
    Schwab BW; Hand H; Costa LG; Murphy SD
    Neurotoxicology; 1981 Dec; 2(4):635-47. PubMed ID: 7200580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enrichment, solubilization, and partial characterization of digitonin-solubilized muscarinic receptors derived from canine ventricular myocardium.
    Manalan AS; Werth DK; Jones LR; Watanabe AM
    Circ Res; 1983 Jun; 52(6):664-76. PubMed ID: 6305530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.
    Wang JX; Roeske WR; Gulya K; Wang W; Yamamura HI
    Life Sci; 1987 Oct; 41(14):1751-60. PubMed ID: 3657382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain.
    Katayama S; Ishizaki F; Yamamura Y; Khoriyama T; Kito S
    Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):261-70. PubMed ID: 2236897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcellular distribution of muscarinic acetylcholine receptors in rat exorbital lacrimal gland.
    Bradley ME; Peters CL; Lambert RW; Yiu SC; Mircheff AK
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):977-86. PubMed ID: 2335459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
    Vickroy TW; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonist interactions with cardiac muscarinic receptors. Effects of Mg2+, guanine nucleotides, and monovalent cations.
    McMahon KK; Hosey MM
    Mol Pharmacol; 1985 Nov; 28(5):400-9. PubMed ID: 4058421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of solubilized muscarinic cholinergic receptors: binding and hydrodynamic properties.
    Baron B; Gavish M; Sokolovsky M
    Arch Biochem Biophys; 1985 Jul; 240(1):281-96. PubMed ID: 4015105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subtype-specific changes in ligand binding properties after solubilization of muscarinic receptors from baculovirus-infected Sf9 insect cell membranes.
    Rinken A
    J Pharmacol Exp Ther; 1995 Jan; 272(1):8-14. PubMed ID: 7815368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of muscarinic receptor subtypes on human peripheral lung.
    Casale TB; Ecklund P
    J Appl Physiol (1985); 1988 Aug; 65(2):594-600. PubMed ID: 3170410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circadian rhythm in muscarinic receptor subtypes in rat forebrain.
    Marquez E; Pavia J; Laukonnen S; Martos F; Gomez A; Rius F; Sanchez de la Cuesta F
    Chronobiol Int; 1990; 7(4):277-82. PubMed ID: 2085868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW; Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
    Waelbroeck M; Gillard M; Robberecht P; Christophe J
    Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscarinic acetylcholine receptor: thermodynamic analysis of the interaction of agonists and antagonists.
    Gies JP; Ilien B; Landry Y
    Biochim Biophys Acta; 1986 Oct; 889(1):103-15. PubMed ID: 3768426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional differences in the binding of selective muscarinic receptor antagonists in rat brain: comparison with minimum-energy conformations.
    Messer WS; Ellerbrock BR; Smith DA; Hoss W
    J Med Chem; 1989 Jun; 32(6):1164-72. PubMed ID: 2724292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
    Zimmerman TW; Binder HJ
    Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cocaine inhibits muscarinic cholinergic receptors in heart and brain.
    Sharkey J; Ritz MC; Schenden JA; Hanson RC; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1048-52. PubMed ID: 3047364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insect muscarinic acetylcholine receptor: pharmacological and toxicological profiles of antagonists and agonists.
    Honda H; Tomizawa M; Casida JE
    J Agric Food Chem; 2007 Mar; 55(6):2276-81. PubMed ID: 17319687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.